Failure and Grace with Mike Reid, MD
Why It Matters
Reid’s insights reveal a critical inflection point in global health financing and governance, and Lenacapavir’s near‑perfect efficacy could dramatically curb HIV transmission if sustainably deployed.
Key Takeaways
- •Nocturnus Plus launches subscriber-only feed with bonus content.
- •Dr. Reid emphasizes handling failure and resilience in global health.
- •PEPFAR transitioning to broader health security, seeking sustainable financing.
- •Lenacapavir shows near‑perfect HIV prevention in phase‑III trials.
- •AI and local governance seen as future global‑health levers.
Summary
The episode opens by announcing Nocturnus Plus, a subscriber‑only feed offering monthly "After Hours" conversations, merchandise discounts, and centralized episode access. Host Emily Silverman then introduces Dr. Mike Reid, an infectious‑disease physician whose career spans the UK, Botswana, and a chief science officer role at PEPFAR, now part of the Bureau of Global Health Security and Diplomacy. Reid shares a formative childhood memory of his father’s self‑deprecating remark, "I'm such a failure," which resurfaces during a heartbreaking HIV case in Botswana, illustrating how clinicians internalize setbacks. He recounts his journey from a transformative high‑school trip to India, through global‑health work in New York and Botswana, to ID training in the US, culminating in his current focus on scaling innovative tools for low‑resource settings. Key moments include Reid quoting Mark Carney on a "moment of rupture" in global health, noting US funding volatility, and highlighting Lenacapavir—a capsid inhibitor achieving 100% efficacy in adolescent girls and 97% in other groups. He also stresses that AI, while not a silver bullet, can create efficiencies amid shrinking budgets. The conversation signals a pivot toward local governance, diversified financing, and technology adoption to sustain progress against HIV and other infectious diseases. For listeners, the subscription model offers deeper insight into the emotional and strategic dimensions of global‑health leadership, while the discussed innovations promise transformative impact if scaled responsibly.
Comments
Want to join the conversation?
Loading comments...